Grandfield & Dodd LLC Grows Position in GE HealthCare Technologies Inc. $GEHC

Grandfield & Dodd LLC boosted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 332,475 shares of the company’s stock after buying an additional 2,827 shares during the quarter. GE HealthCare Technologies makes up approximately 1.4% of Grandfield & Dodd LLC’s investment portfolio, making the stock its 23rd biggest holding. Grandfield & Dodd LLC owned about 0.07% of GE HealthCare Technologies worth $24,626,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of GEHC. Trustco Bank Corp N Y lifted its holdings in shares of GE HealthCare Technologies by 4.8% during the 2nd quarter. Trustco Bank Corp N Y now owns 7,261 shares of the company’s stock valued at $538,000 after purchasing an additional 334 shares during the last quarter. Schwarz Dygos Wheeler Investment Advisors LLC boosted its holdings in GE HealthCare Technologies by 25.2% in the second quarter. Schwarz Dygos Wheeler Investment Advisors LLC now owns 6,987 shares of the company’s stock valued at $518,000 after purchasing an additional 1,406 shares during the last quarter. Allianz SE grew its holdings in GE HealthCare Technologies by 165.2% during the second quarter. Allianz SE now owns 350 shares of the company’s stock worth $26,000 after acquiring an additional 218 shares during the period. First Western Trust Bank grew its stake in shares of GE HealthCare Technologies by 19.5% during the 2nd quarter. First Western Trust Bank now owns 3,346 shares of the company’s stock worth $248,000 after purchasing an additional 545 shares during the period. Finally, Impax Asset Management Group plc increased its holdings in GE HealthCare Technologies by 76.5% in the second quarter. Impax Asset Management Group plc now owns 15,434 shares of the company’s stock valued at $1,143,000 after buying an additional 6,689 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Analysts Set New Price Targets

GEHC has been the topic of a number of recent analyst reports. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Tuesday. Barclays started coverage on shares of GE HealthCare Technologies in a research report on Monday, October 13th. They set an “equal weight” rating and a $86.00 price objective for the company. Evercore ISI increased their price target on GE HealthCare Technologies from $88.00 to $92.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. Morgan Stanley boosted their price objective on GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a report on Thursday, October 30th. Finally, BTIG Research set a $87.00 target price on GE HealthCare Technologies in a report on Wednesday, October 29th. Six research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $86.10.

GE HealthCare Technologies Price Performance

GEHC stock opened at $73.97 on Friday. The business has a 50 day moving average price of $75.20 and a 200 day moving average price of $73.65. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. The stock has a market cap of $33.69 billion, a price-to-earnings ratio of 15.28, a PEG ratio of 2.82 and a beta of 1.13. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, beating the consensus estimate of $1.05 by $0.02. The company had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The firm’s revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the firm posted $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio is currently 2.89%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.